[go: up one dir, main page]

MX2018015184A - Métodos para el diagnóstico de infecciones bacterianas y virales. - Google Patents

Métodos para el diagnóstico de infecciones bacterianas y virales.

Info

Publication number
MX2018015184A
MX2018015184A MX2018015184A MX2018015184A MX2018015184A MX 2018015184 A MX2018015184 A MX 2018015184A MX 2018015184 A MX2018015184 A MX 2018015184A MX 2018015184 A MX2018015184 A MX 2018015184A MX 2018015184 A MX2018015184 A MX 2018015184A
Authority
MX
Mexico
Prior art keywords
bacterial
diagnosis
methods
viral infections
viral
Prior art date
Application number
MX2018015184A
Other languages
English (en)
Inventor
KHATRI Purvesh
e sweeney Timothy
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MX2018015184A publication Critical patent/MX2018015184A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se describen métodos para el diagnóstico de infecciones bacterianas y virales. En particular, la invención se refiere al uso de biomarcadores que pueden determinar si un paciente con inflamación aguda tiene una infección bacteriana o viral.
MX2018015184A 2016-06-07 2017-06-05 Métodos para el diagnóstico de infecciones bacterianas y virales. MX2018015184A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662346962P 2016-06-07 2016-06-07
PCT/US2017/036003 WO2017214061A1 (en) 2016-06-07 2017-06-05 Methods for diagnosis of bacterial and viral infections

Publications (1)

Publication Number Publication Date
MX2018015184A true MX2018015184A (es) 2019-04-24

Family

ID=60578903

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018015184A MX2018015184A (es) 2016-06-07 2017-06-05 Métodos para el diagnóstico de infecciones bacterianas y virales.
MX2024009339A MX2024009339A (es) 2016-06-07 2018-12-06 Biomarcadores utiles en el diagnostico de infecciones bacterianas y virales.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2024009339A MX2024009339A (es) 2016-06-07 2018-12-06 Biomarcadores utiles en el diagnostico de infecciones bacterianas y virales.

Country Status (11)

Country Link
US (2) US11274345B2 (es)
EP (1) EP3464645A4 (es)
JP (2) JP2019520042A (es)
KR (2) KR102515555B1 (es)
CN (1) CN109312411A (es)
AU (2) AU2017278254A1 (es)
BR (1) BR112018075288A2 (es)
CA (1) CA3022616A1 (es)
IL (2) IL262762B2 (es)
MX (2) MX2018015184A (es)
WO (1) WO2017214061A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201806052D0 (en) 2018-04-12 2018-05-30 Univ Liverpool Detection of bacterial infections
WO2019217296A1 (en) * 2018-05-07 2019-11-14 Yale University Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
WO2020030609A1 (en) * 2018-08-04 2020-02-13 Imperial College Of Science, Technology And Medicine Method of identifying a subject having kawasaki disease
AU2019345037A1 (en) * 2018-09-19 2021-05-13 Inflammatix, Inc. Assessing host RNA using isothermal amplification and relative abundance
US11369318B2 (en) 2019-05-31 2022-06-28 Light Ai, Inc. Image processing of streptococcal infection in pharyngitis subjects
CA3115738A1 (en) * 2018-10-09 2020-04-16 Light AI Inc. Image processing of streptococcal infection in pharyngitis subjects
WO2020161206A1 (en) * 2019-02-05 2020-08-13 Universidade De Santiago De Compostela In vitro method for the diagnosis of viral infections
CN113614831A (zh) * 2019-03-22 2021-11-05 英芙勒玛提克斯公司 用于从多个数据集导出和优化分类器的系统和方法
EP3947735A4 (en) * 2019-03-25 2022-12-28 The Board Of Trustees Of The Leland Stanford Junior University SIGNATURE FOR DIAGNOSIS OF BACTERIAL VS VIRAL INFECTIONS
US11104946B2 (en) * 2019-04-23 2021-08-31 Inflammatix, Inc. DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome
CN110082338A (zh) * 2019-05-15 2019-08-02 广西科技大学 超顺磁性Fe3O4@SiO2@Ag纳米复合材料用于对苯唑西林SERS检测的方法
EP3817005A1 (en) * 2019-11-01 2021-05-05 Koninklijke Philips N.V. System for infection diagnosis
KR20220098002A (ko) * 2019-11-13 2022-07-08 더 리전츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코퍼레이트 감염의 숙주 rna 바이오마커의 식별
US20230016954A1 (en) 2019-12-11 2023-01-19 Ichilov Tech Ltd. Non-invasive assay for differentiating between bacterial and viral infections
US12148150B2 (en) 2020-03-19 2024-11-19 Light AI Inc. Infection detection using image data analysis
WO2021192320A1 (ja) * 2020-03-27 2021-09-30 株式会社島津製作所 新型コロナウイルスの検査方法および検査試薬
KR102422238B1 (ko) * 2020-04-27 2022-07-18 경북대학교 산학협력단 TGFBIp의 아세틸화 수준을 측정하는 제제를 포함하는 중증급성호흡기증후군 바이러스 2 진단용 조성물
WO2021221863A1 (en) * 2020-04-28 2021-11-04 Heeger, Brandon Rapid testing mechanism and method for respiratory viral pathogens
CN111848772B (zh) * 2020-08-03 2022-03-18 山东绿都生物科技有限公司 SAMD9突变型蛋白、Vero细胞系及其构建方法和应用
WO2022045126A1 (ja) * 2020-08-25 2022-03-03 学校法人 久留米大学 ウイルス感染の判定方法
EP4308729B1 (en) * 2021-03-16 2025-10-29 Cepheid Methods for discriminating bacterial and viral infections in a human subject
EP4334474A4 (en) * 2021-05-04 2025-09-10 Inflammatix Inc SYSTEMS AND METHODS FOR ASSESSING A BACTERIAL OR VIRAL STATUS OF A SAMPLE
CN115029426B (zh) * 2022-04-19 2025-05-27 武汉大学中南医院 冠心病诊断剂及dysf基因甲基化在制备冠心病诊断剂中的应用
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate
WO2025059317A1 (en) * 2023-09-13 2025-03-20 President And Fellows Of Harvard College Transcriptomic signatures for identifying drug-susceptible mycobacterium tuberculosis complex
KR20250075010A (ko) 2023-11-21 2025-05-28 바디텍메드(주) 믹소바이러스 내성 단백질 a와 c-반응성 단백질을 이용한 박테리아감염과 바이러스감염 구별을 위한 진단 시스템
CN118127149B (zh) * 2024-05-10 2024-07-09 天津云检医学检验所有限公司 一种用于评估受试者的败血症风险和感染型的生物标志物、模型及试剂盒
CN119479830B (zh) * 2025-01-15 2025-05-16 北京大学 一种多中心数据聚合方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040038201A1 (en) * 2002-01-22 2004-02-26 Whitehead Institute For Biomedical Research Diagnostic and therapeutic applications for biomarkers of infection
WO2007059119A2 (en) * 2005-11-11 2007-05-24 Ivan Borozan Systems and methods for identifying diagnostic indicators
MX2008013796A (es) * 2006-04-26 2009-03-31 Vertex Pharma Biomarcadores de infeccion por el virus de hepatitis c.
EP2561363B1 (en) 2010-04-21 2021-07-14 Memed Diagnostics, Ltd. Signatures and determinants for distinguishing between a bacterial and viral infection and methods of use thereof
CA2806291C (en) 2010-07-23 2023-08-29 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
GB201201766D0 (en) * 2012-02-01 2012-03-14 Imp Innovations Ltd Method
CN108802385B (zh) * 2012-02-09 2022-02-08 米密德诊断学有限公司 用于诊断感染的标记和决定因素和其使用方法
WO2013162651A1 (en) * 2012-04-28 2013-10-31 Us Army Center For Environmental Health Research(Cehr) Biomarkers of immune dysfunction in response to chronic stress, methods of use and diagnostic kits
US20150099655A1 (en) * 2012-05-08 2015-04-09 The Board Of Trustees Of The Leland Stanford Junior University Methods and Compositions for Providing a Preeclampsia Assessment
EP4219761A1 (en) 2013-03-15 2023-08-02 Veracyte, Inc. Biomarkers for diagnosis of lung diseases and methods of use thereof
SG11201510282PA (en) * 2013-06-28 2016-01-28 Acumen Res Lab Pte Ltd Sepsis biomarkers and uses thereof
US20160291024A1 (en) * 2013-09-17 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Biomarkers for Ovarian Cancer
WO2015048098A1 (en) * 2013-09-24 2015-04-02 Washington University Diagnostic methods for infectious disease using endogenous gene expression
GB201406259D0 (en) * 2014-04-07 2014-05-21 Univ Edinburgh Molecular predictors of neonatal sepsis
JP6788586B2 (ja) * 2014-11-19 2020-11-25 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． Ｈｎｌを用いる診断方法

Also Published As

Publication number Publication date
IL312537A (en) 2024-07-01
EP3464645A4 (en) 2020-05-06
BR112018075288A2 (pt) 2019-03-19
CA3022616A1 (en) 2017-12-14
IL312537B1 (en) 2025-09-01
JP7750895B2 (ja) 2025-10-07
US11274345B2 (en) 2022-03-15
IL262762B2 (en) 2024-10-01
AU2023226757A1 (en) 2023-09-28
JP2023098945A (ja) 2023-07-11
IL262762B1 (en) 2024-06-01
WO2017214061A1 (en) 2017-12-14
US20220127673A1 (en) 2022-04-28
AU2017278254A1 (en) 2018-11-15
JP2019520042A (ja) 2019-07-18
EP3464645A1 (en) 2019-04-10
KR20190015294A (ko) 2019-02-13
MX2024009339A (es) 2024-08-09
KR20230049750A (ko) 2023-04-13
KR102515555B1 (ko) 2023-03-28
KR20240100488A (ko) 2024-07-01
CN109312411A (zh) 2019-02-05
IL312537B2 (en) 2026-01-01
US20190144943A1 (en) 2019-05-16
IL262762A (en) 2018-12-31

Similar Documents

Publication Publication Date Title
MX2018015184A (es) Métodos para el diagnóstico de infecciones bacterianas y virales.
CY1122653T1 (el) Αντισωματα αντι-τιgιτ, αντισωματα αντι-ρvrig και συνδυασμοι εξ αυτων
CL2023001550A1 (es) Sistemas activos dinámicos acromosómicos.
CL2017000285A1 (es) Terapia combinada para el tratamiento de un paramixovirus
CL2022000087A1 (es) Anticuerpo anti-tau y uso del mismo
MX2017014136A (es) Anticuerpos anti-cd166, anticuerpos anti-cd166 activables, y metodos de uso de los mismos.
MX2017015464A (es) Anticuerpos anti-tau y metodos de uso.
MX2017005920A (es) Anticuerpos anti-tim3 y metodos de uso.
MX2024011869A (es) Anticuerpos anti-tau y metodos de uso
CL2017000590A1 (es) Anticuerpos anti-cll-1 e inmunoconjugados
PL3506886T3 (pl) Wysoko stężone preparaty przeciwciał hamujących masp-2 o niskiej lepkości, zestawy i sposoby
MX386587B (es) ANTICUERPOS ANTI-CD79b Y MÉTODOS DE USO.
TR201810635T4 (tr) Anti-jagged1 antikorları ve kullanım yöntemleri.
CR20190271A (es) Anticuerpos antitau y métodos de uso
JOP20190256A1 (ar) فيروسات داء نيوكاسل واستخداماتها
MX2015016627A (es) Vacuna para la malaria.
CL2015002472A1 (es) Como inhibidores de mutant idh-yl-oxazolidin-2-onas 3-pirimidin-4.
MX2020003515A (es) Laminados elasticos con elasticos curvos y metodos para la fabricacion.
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
CL2016002223A1 (es) Microorganismo recombinante que expresa análogos de avermectina y uso de los mismos.
MX2020009465A (es) Anticuerpos anti-klk5 y metodos de uso.
MX389026B (es) Una composicion farmaceutica y el uso de la misma.
CL2018001279A1 (es) Spodoptera frugiperda resistente a vip3a.
CL2017003309A1 (es) Métodos de purificación y/o inactivación viral